References
Bhattacharyya I, Islam MN, Yoon TY, Green JG, Ohja J, Liu JJ, Cohen DM. Lip hypertrophy secondary to cyclosporine treatment: a rare adverse effect and treatment considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(4):469–74.
Bostrom A, Bharath H, Saulewicz A, Narayanan AS. Cyclosporin A affects signaling events differentially in human gingival fibroblasts. J Dent Res. 2005;84:532–6.
Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial. Am J Kidney Dis. 2009;53(5):760–9.
Gomez E, Sanchez-Nunez M, Sanchez JE, Corte C, Aguado S, Portal C, et al. Treatment of cyclosporine-induced gingival hyperplasia with azithromycin. Nephrol Dial Transplant. 1997;12:2694–7.
Conflict of interest
All the authors have declared no competing interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kapoor, K., Saha, A. & Dubey, N.K. Lip hypertrophy due to cyclosporine therapy. Clin Exp Nephrol 18, 168–169 (2014). https://doi.org/10.1007/s10157-013-0808-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-013-0808-6